Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines

[1] Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New Engl J Med 352 987-996

[2] Mason WP(2023)Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy Bioelectrochemistry 149 108287-3658

[3] van den Bent MJ(2022)The mechanisms of action of Tumor Treating Fields Can Res 82 3650-1054

[4] Weller M(2021)An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications Int J Radiat Biol 97 1044-2316

[5] Fisher B(2017)Effect of Tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial JAMA 318 2306-2543

[6] Taphoorn MJ(2015)Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial JAMA 314 2535-43

[7] Belanger K(2017)Chemotherapeutic drugs: DNA damage and repair in glioblastoma Cancers (Basel) 9 57-141

[8] Brandes AA(2012)Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma Front Oncol 2 186-1003

[9] Marosi C(2021)Mechanisms of temozolomide resistance in glioblastoma—a comprehensive review Cancer Drug Resist 4 17-1354

[10] Bogdahn U(2019)DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas DNA Repair (Amst) 78 128-1172

[1] Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New Engl J Med 352 987-996

[2] Mason WP(2023)Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy Bioelectrochemistry 149 108287-3658

[3] van den Bent MJ(2022)The mechanisms of action of Tumor Treating Fields Can Res 82 3650-1054

[4] Weller M(2021)An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications Int J Radiat Biol 97 1044-2316

[5] Fisher B(2017)Effect of Tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial JAMA 318 2306-2543

[6] Taphoorn MJ(2015)Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial JAMA 314 2535-43

[7] Belanger K(2017)Chemotherapeutic drugs: DNA damage and repair in glioblastoma Cancers (Basel) 9 57-141

[8] Brandes AA(2012)Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma Front Oncol 2 186-1003

[9] Marosi C(2021)Mechanisms of temozolomide resistance in glioblastoma—a comprehensive review Cancer Drug Resist 4 17-1354

[10] Bogdahn U(2019)DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas DNA Repair (Amst) 78 128-1172